| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | Index-Update: Walmart verdrängt AstraZeneca im Nasdaq 100 | 809 | börsennews.de | Der US-Einzelhandelsgigant Walmart Inc. steigt in den Nasdaq 100 Index auf und ersetzt dort den Pharmakonzern AstraZeneca. Wie der Indexanbieter Nasdaq am Freitag bekannt gab, werden die Änderungen... ► Artikel lesen | |
| So | NurExone rückt auf der JPM Healthcare Week 2026 als innovativer Biotech-Akteur in den Fokus | Small- & Micro Cap Investment | |||
| So | Schott Pharma: Technische Ausgangslage und Kursziel | RuMaS | |||
| So | Teva Pharmaceutical Industries Ltd: Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo | 227 | GlobeNewswire (Europe) | Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-'408... ► Artikel lesen | |
| So | Faruqi & Faruqi LLP: DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience | 196 | Newsfile | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Skye to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired... ► Artikel lesen | |
| 00:10 | Teva Pharmaceutical Industries Ltd: Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation | 157 | GlobeNewswire (Europe) | Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time)TEL AVIV... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| PERRIGO | 12,890 | 1,00 | +7,76 % | 0,29 | 28.11.2025 | |
| PFIZER | 21,900 | 1,48 | +6,76 % | 0,43 | 23.01.2026 | |
| BRISTOL-MYERS SQUIBB | 47,970 | 2,12 | +4,42 % | 0,63 | 02.01.2026 | |
| SHANGHAI PHARMACEUTICALS | 1,250 | 0,05 | +4,00 % | 0,13 | 29.12.2025 | |
| VIATRIS | 10,930 | 0,42 | +3,84 % | 0,12 | 24.11.2025 | |
| ONO PHARMACEUTICAL | 12,200 | 0,44 | +3,61 % | 40,00 | 30.03.2026 | |
| FAES FARMA | 5,270 | 0,18 | +3,42 % | 0,04 | 08.01.2026 | |
| GSK | 21,750 | 0,73 | +3,36 % | 0,16 | 13.11.2025 | |
| ASTELLAS PHARMA | 12,320 | 0,41 | +3,33 % | 39,00 | 30.03.2026 | |
| EISAI | 26,910 | 0,87 | +3,23 % | 80,00 | 30.03.2026 |